“Photo-Rimonabant”: Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar “Cis-On” CB1R Antagonist
Author(s) -
Diego A. RodríguezSoacha,
Julia Fender,
Yesid A. Ramírez,
Juan A. Collado,
Eduardo Muñóz,
Rangan Maitra,
Christoph Sotriffer,
Kristina Lorenz,
Michael Decker
Publication year - 2021
Publication title -
acs chemical neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.158
H-Index - 69
ISSN - 1948-7193
DOI - 10.1021/acschemneuro.1c00086
Subject(s) - rimonabant , antagonist , endocannabinoid system , chemistry , cannabinoid , cannabinoid receptor , stereochemistry , docking (animal) , radioligand , cannabinoid receptor antagonist , combinatorial chemistry , pharmacology , in vitro , receptor , biochemistry , biology , medicine , nursing
Human cannabinoid receptor type 1 ( h CB 1 R) plays important roles in the regulation of appetite and development of addictive behaviors. Herein, we describe the design, synthesis, photocharacterization, molecular docking, and in vitro characterization of "photo-rimonabant", i.e., azo-derivatives of the selective h CB 1 R antagonist SR1411716A (rimonabant). By applying azo-extension strategies, we yielded compound 16a , which shows marked affinity for CB 1 R ( K i ( cis form) = 29 nM), whose potency increases by illumination with ultraviolet light (CB 1 R K i trans / cis ratio = 15.3). Through radioligand binding, calcium mobilization, and cell luminescence assays, we established that 16a is highly selective for h CB 1 R over h CB 2 R. These selective antagonists can be valuable molecular tools for optical modulation of CBRs and better understanding of disorders associated with the endocannabinoid system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom